New York State Common Retirement Fund Galapagos Nv Transaction History

New York State Common Retirement Fund

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$24.78 - $32.48 $2,131 - $2,793	86 Added 15.52%	640 $16,000
Q1 2024 May 07, 2024	SELL	$32.2 - $42.44 $1,288 - $1,697	-40 Reduced 6.73%	554 $18,000
Q4 2023 Feb 01, 2024	SELL	$31.87 - $40.71 $6,246 - $7,979	-196 Reduced 24.81%	594 $24,000
Q3 2023 Nov 07, 2023	SELL	$34.17 - $42.98 $2,323 - $2,922	-68 Reduced 7.93%	790 $27,000
Q2 2023 Aug 07, 2023	BUY	$37.4 - $44.52 $9,350 - $11,130	250 Added 41.12%	858 $35,000
Q1 2023 May 02, 2023	BUY	$36.5 - $48.0 $22,192 - $29,184	608 New	608 $23,000
Q3 2020 Nov 05, 2020	SELL	$122.47 - $213.56 $171,458 - $298,984	-1,400 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$146.12 - $215.82 $204,568 - $302,148	1,400 New	1,400 $290,000
Q3 2017 Nov 06, 2017	SELL	$73.17 - $103.47 $158,998 - $224,840	-2,173 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	2,173	2,173 $166,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.87B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.